Accretion Nutraveda IPO Date, Review, Price, Allotment Details
Accretion Nutraveda IPO is scheduled to open for subscription on January 28, 2026, and will close on January 30, 2026. It is a book-built issue through which the company plans to raise approximately ₹24.77 crore. The IPO comprises a fresh issue worth ₹24.77 crore, along with an offer for sale of up to [.] equity shares, each having a face value of ₹10.
The price band for the Accretion Nutraveda IPO has been fixed at ₹122 to ₹129 per share. The issue allocation includes 50% for QIBs, 35% for retail investors, and 15% for HNIs. The shares are proposed to be listed on the BSE SME platform on February 4, 2026, while the allotment is expected to be finalized on February 2, 2026.
From a financial perspective, the company reported revenue of ₹16.06 crore in FY2025 compared to ₹5.20 crore in FY2024. Net profit also rose to ₹2.61 crore in FY2025 from ₹0.82 crore in FY2024. Based on the company’s financial performance, the IPO may be suitable for investors with a long-term investment outlook.
Accretion Nutraveda IPO Details
IPO Open Date January 28, 2026 IPO Close Date January 30, 2026 Face Value ₹10 Per Equity Share IPO Price Band ₹122 to ₹129 Per Share Issue Size Approx ₹24.77 Crores Fresh Issue Approx ₹24.77 Crores Issue Type Book Build Issue IPO Listing BSE SME DRHP Draft Prospectus 
RHP Draft Prospectus
Accretion Nutraveda IPO Review & Key Points
- Review:
Accretion Nutraveda IPO Market Lot
The minimum market lot for the Accretion Nutraveda IPO is 2,000 shares, requiring an application amount of ₹2,58,000.
Application Lot Size Shares Amount Retail Minimum 2 2,000 ₹2,58,000 Retail Maximum 2 2,000 ₹2,58,000 S-HNI Minimum 3 3,000 ₹3,87,000 S-HNI Maximum 7 7,000 ₹9,03,000 B-HNI Minimum 8 8,000 ₹10,32,000
IPO Reservation
Investor Category Share Offered -% Shares Anchor Investor 5,46,000 Shares 28.44% QIB (Ex. Anchor) 3,62,000 Shares 18.85% NII Shares Offered 2,76,000 Shares 14.37% Retail Shares Offered 6,40,000 Shares 33.33%
Accretion Nutraveda IPO Anchor Investors
Anchor Bidding Date January 27, 2026 Anchor Investors List Shares Offered 5,46,000 Shares Anchor Size 7.04 Cr. lock-in period end date 50% shares (30 Days) March 4, 2026 lock-in period end date 50% shares (90 Days) May 3, 2026
Accretion Nutraveda IPO Dates
The Accretion Nutraveda IPO date is January 28 and the close date is January 30. The Accretion Nutraveda IPO allotment will be finalized on February 2 and the IPO listing on February 4.
IPO Open Date: January 28, 2026 IPO Close Date: January 30, 2026 Basis of Allotment: February 2, 2026 Refunds: February 3, 2026 Credit to Demat Account: February 3, 2026 IPO Listing Date: February 4, 2026 IPO Bidding Cut-off Time: January 30, 2026 – 5 PM
Promoters and Holding Pattern
The promoters of the company are Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod, and Mr. Vivek Ashok Kumar Patel.
Particular Shares % Share Promoter Holding Pre-Issue 53,20,000 100% Promoter Holding Post Issue 72,40,000 73.48%
Objects of the Issue & Utilisation of Proceeds
Purpose Crores Purchase of machinery for Automation in the existing Manufacturing unit ₹4.22 Purchase of Machinery for New Manufacturing Setup ₹8.03 Funding the working capital requirements of our company ₹5.50 General Corporate Purpose ₹-
About Accretion Nutraveda IPO
Since its incorporation in 2021, Accretion Nutraveda has been engaged in the manufacturing of Ayurvedic and nutraceutical products in India. The company offers a wide range of products in various forms and dosages, including tablets, capsules, oral liquids, powders, oils, and external preparations such as balms, creams, and gels.
Accretion Nutraveda serves customers both in India and internationally, including markets like Sri Lanka, Singapore, and the USA. The company combines traditional Ayurvedic knowledge with modern scientific approaches to provide solutions for areas such as liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness. Its 10,763 sq. ft. manufacturing facility in Gujarat is equipped with modern infrastructure and advanced quality control systems to ensure high standards of production.
Accretion Nutraveda IPO Company Financial Report
Amount ₹ in Crores
Period Ended Revenue Expense PAT Assets 2023 ₹3.07 ₹2.78 ₹0.28 ₹4.06 2024 ₹5.20 ₹4.28 ₹0.82 ₹4.64 2025 ₹16.06 ₹12.87 ₹2.61 ₹10.86 Sep 2025 ₹14.07 ₹11.20 ₹2.33 ₹16.35
Accretion Nutraveda IPO Valuation – FY2025
Check Accretion Nutraveda IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
KPI Values ROE: 81.22% ROCE: 36.98% EBITDA Margin: 22.79% PAT Margin: 16.33% Debt to equity ratio: – Earning Per Share (EPS): ₹7.19 (Basic) Price/Earning P/E Ratio: N/A Return on Net Worth (RoNW): 48.85% Net Asset Value (NAV): ₹14.72
Peer Group Comparison
Company EPS PE Ratio RoNW % NAV Income Walpar Nutritions Ltd. 1.80 23.94 11.27% 13.65 60.26 Cr. Influx Healthtech Limited 7.31 25.93 36.72% 5.31 104.99 Cr.
IPO Lead Managers aka Merchant Bankers
- Sobhagya Capital Options Pvt. Ltd.
Company Address
Accretion Nutraveda Ltd.
27 Xcelon Industrial Park-1
Vasna-Chacharwadi, TaSanand,
Ahmedabad, Gujarat, 382213
Phone: +91- 9904366177
Email: compliance@accretionnutraveda.com
Website: http://www.accretionnutraveda.com/
IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: apl.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/